OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ALNY

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Alnylam Pharmaceuticals (ALNY) Earnings Date & Reports

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ALNY is expected to report earnings to rise 7,030.00% to -71 cents per share on July 31

Alnylam Pharmaceuticals ALNY Stock Earnings Reports

Q2'25

Est.

$-0.71

Q1'25

Beat

by $0.92

Q4'24

Beat

by $0.64

Q3'24

Beat

by $0.43

Q2'24

Beat

by $1.61

The last earnings report on May 01 showed earnings per share of 0 cents, beating the estimate of -93 cents. With 199.18K shares outstanding, the current market capitalization sits at 38.15B.

View a ticker or compare two or three

Compare

Earnings Traders Earnings Traders

Annualized Return+24%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

ALNY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALNY
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View to see Real Time Patterns for ALNY (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

675 West Kendall Street

Phone

+1 617 551-8200

Employees

2100

Web

https://www.alnylam.com